Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Dec;10(6):875-877.
doi: 10.21037/hbsn-21-404.

The role of B cells in metabolic (dysfunction)-associated fatty liver disease

Ziyan Pan  1 , Wah-Kheong Chan  2 , Mohammed Eslam  1
Affiliations
Editorial

The role of B cells in metabolic (dysfunction)-associated fatty liver disease

Ziyan Pan et al. Hepatobiliary Surg Nutr. 2021 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://dx.doi.org/10.21037/hbsn-21-404). Dr. ME serves as an unpaid editorial board member of Hepatobiliary Surgery and Nutrition. Dr. WKC has served as a consultant for Boehringer Ingelheim and Novo Nordisk; and a speaker for Novo Nordisk, Viatris and Hisky Medical. The other author has no conflicts of interest to declare.

Comment on

References

    1. Sarin SK, Kumar M, Eslam M, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol 2020;5:167-228. 10.1016/S2468-1253(19)30342-5 - DOI - PMC - PubMed
    1. Petta S, Eslam M, Valenti L, et al. Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study. Liver Int 2017;37:1389-96. 10.1111/liv.13397 - DOI - PubMed
    1. Bayoumi A, Grønbæk H, George J, et al. The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease. Trends Genet 2020;36:429-41. 10.1016/j.tig.2020.03.003 - DOI - PubMed
    1. Eslam M, George J. Genetic Insights for Drug Development in NAFLD. Trends Pharmacol Sci 2019;40:506-16. 10.1016/j.tips.2019.05.002 - DOI - PubMed
    1. Eslam M, Sarin SK, Wong VW, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int 2020;14:889-919. 10.1007/s12072-020-10094-2 - DOI - PubMed